BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The majority of HIV infected people worldwide became infected with the virus through
heterosexual contact. BufferGel and PRO 2000 Gel are vaginal gels designed to prevent women
from becoming infected with HIV during sexual intercourse with an HIV infected partner. This
study will test the safety and effectiveness of these gels.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) HIV Prevention Trials Network National Institute of Mental Health (NIMH) National Institute on Drug Abuse (NIDA)